Clinical trial Recruiting at 1 site Interventional Ages 0 to 18

Comparing anti-reflux stents and standard stents in children with kidney stones

Official title: Comparison of the Drainage/Anti-reflux Effect and Stent-Related Symptoms Between Anti-Reflux Stents and Standard DJ Stents in Children With Urolithiasis

Run by The Children's Hospital of Zhejiang University School of Medicine · NCT06569173 · Data updated 2026-11-12

This study is testing if special anti-reflux stents can help children with kidney stones recover better and have fewer complications after surgery compared to regular stents.

More Urolithiasis trials

Quick facts

Study typeInterventional
Ages0 Years to 18 Years
SexAll
Enrollment108 (estimated)
SponsorThe Children's Hospital of Zhejiang University School of Medicine
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedAugust 23, 2024
Main results expectedAugust 23, 2025
Study endsAugust 23, 2025
Registry record updatedNovember 12, 2024
Trial IDNCT06569173 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children under 18 years old with a confirmed diagnosis of urinary tract stones requiring surgical intervention.

Probably not a fit

Patients with a history of recurrent bladder irritative symptoms or urinary tract infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness and complications of anti-reflux stents versus conventional stents in pediatric patients undergoing surgery for urolithiasis. Ureteral stents are essential for supporting the ureter and facilitating urine drainage post-surgery, but they can cause complications like urinary tract infections and lumbar pain. The study aims to determine if anti-reflux stents, designed to prevent urine reflux, can reduce these symptoms and improve recovery quality in children. This is the first pediatric study to evaluate the efficacy of anti-reflux stents in this context.

Why it matters

Potential benefit: If successful, this study could lead to improved postoperative recovery and quality of life for children undergoing urolithiasis surgery.

How similar studies have gone: While adult studies suggest potential benefits of anti-reflux stents, this pediatric approach is novel and has not been previously tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. A definitive diagnosis of urinary tract stones by CT scan, with indications for ureteroscopic lithotripsy (URL), percutaneous nephrolithotomy (PCNL), laparoscopic/open stone extraction with or without robotic assistance, or combined endoscopic lithotripsy, and no contraindications;
2. Age is less than 18 years old;
3. For preschool children, the informed consent form is signed by the parents; for school-age children, the informed consent form is signed by both the parents and the child themselves.

Exclusion Criteria:

1. A history of recurrent bladder irritative symptoms or urinary tract infections;
2. Severe renal insufficiency, anatomical or functional solitary kidney, and other significant comorbidities that render the child unsuitable for participation in the study;
3. Stent placement surgery within the past 3 months;
4. Recent use of medications that may interfere with the study results, such as solifenacin;
5. Stent removal surgery performed at an external medical facility.

Where it's running

  • Children's hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

  • Principal investigator: Hongbo Liu — The Children's Hospital of Zhejiang University School of Medicine
  • Study coordinator: Aimei Ma
  • Email: maaimei@zju.edu.cn
  • Phone: +86 15888864134

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.